CLINICAL_TRIALS
trial_result
· 2023-10-05
Clinical Trial Update: Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis [Phase 2]
Summary
Phase 2 clinical trial evaluating sarilumab in glucocorticoid-dependent sarcoidosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Sarcoidosis | Phase 2 | Status: COMPLETED | Results posted: 2023-10-05